Returns on Capital Paint A Bright Future For APT Medical (SHSE:688617)
China Approves APT Medical Unit's Atrial Fibrillation Treatment Device
APT Medical Gets Registration Certificate for Two Cardiac Devices
APT Medical Inc.'s (SHSE:688617) Share Price Could Signal Some Risk
We Think That There Are Issues Underlying APT Medical's (SHSE:688617) Earnings
Is APT Medical Inc.'s (SHSE:688617) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention
APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%
Is APT Medical (SHSE:688617) Using Too Much Debt?
APT Medical Gets Registration Certificate for Catheter
Risks Still Elevated At These Prices As APT Medical Inc. (SHSE:688617) Shares Dive 27%
APT Medical Inc.'s (SHSE:688617) Stock Has Fared Decently: Is the Market Following Strong Financials?
Institutional Investors in APT Medical Inc. (SHSE:688617) See CN¥2.3b Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Some Shareholders Feeling Restless Over APT Medical Inc.'s (SHSE:688617) P/E Ratio
Calculating The Fair Value Of APT Medical Inc. (SHSE:688617)
Additional Considerations Required While Assessing APT Medical's (SHSE:688617) Strong Earnings
APT Medical's 2023 Profit Jumps 49%
Investors Should Be Encouraged By APT Medical's (SHSE:688617) Returns On Capital
Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership
Subdued Growth No Barrier To APT Medical Inc.'s (SHSE:688617) Price
No Data